Contact us to find out if we have the data you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple language support. Please visit our Contact page to see which office is open right now!

Summary This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The more…

Research Objectives Antibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and more…

Executive Summary This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug more…

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market more…

Executive Summary The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of more…

Executive Summary Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug more…

Overview Introduction Antibody-based agents represent a novel approach to the treatment and prophylaxis of infectious diseases. In recent years, considerable interest has been more…

Abstract INTRODUCTION Our key objective was to present a comprehensive analysis of the current monoclonal antibody market and its future direction. SCOPE OF STUDY more…

This research service analyses the market landscape, challenges, drivers, restraints and opportunities for the global immunochemicals market. more…

Overview Introduction NICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had more…

Overview Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing tr more…

Executive Summary The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy more…

Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and more…

This new management report covers 30 leading compounds and is essential reading for everyone working in the field. After years of anticipation and encouraging responses to more…

Cytokines have drawn immense interest from the pharmaceutical industry over the last two decades. Great effort has been devoted to finding ways to reproduce their effects- or more…

In 2005, the antibodies market was valued at an estimated US$14 billion, accounting for over 24 percent of the total protein therapeutics market. This share increased more…

Executive Summary In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Apoptopic agents, Antibodies and Vaccines in more…

The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of more…

This report analyzes the worldwide markets for Antivirals in US$ Million. The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) more…

This is the most comprehensive report covering worldwide markets of Monoclonal Antibody Based Products. more…

Introduction Although protein-based therapeutics were seen as a risky and diffi cult fi eld of endeavor, the biopharmaceutical industry's persistent pursuit of such agents more…

In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Melanoma Therapeutics, Antibodies and Vaccines in Oncology, which more…

Overview Introduction Systemic Lupus Erythematosus is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable more…

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Current research is focusing on the urgent unmet need for agents that improve survival. more…

In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Lymphoma, Protein Kinase Inhibitors and Therapeutic Antibodies, more…

Overview Introduction Overview of current approaches being explored to modulate immune system response to allergens more…

Overview Introduction In 2005, around 30,000 renal transplants were conducted in the seven major markets. In order to prevent the patient's immune system from rejecting the tr more…

Overview Introduction Although only 5% of asthma suffers have severe asthma, these patients account for a disproportionately high percentage of healthcare spending, as asthma- more…

The growing demands for existing biologics production are reflected in biopharmaceutical sales figures: The top 15 products in 2004 posted revenues of $38 billion. Although more…

More than 100 companies are developing or have developed antibody array and/or bead platforms. The competition is fierce, but the progress in the field has been slow. The more…

Overview Introduction The targeted therapies market is relatively new in comparison to the cytotoxic and anti-hormonal therapies markets, and will therefore continue to show d more…

Limited Efficacy of Conventional Therapies Kindle Interest in Antibody Technology The limited efficacy of conventional therapies, especially in the case of several autoimmune more…

Significant Product Benefits to Break Down Customer Reluctance toward Adopting New Assays End-user skepticism regarding the reliability of new assays for in-vitro diagnostics more…

This Report covers the Dynamic Antibody Industry more…

Inflammatory Disease Therapeutics: Pipelines and Competitive Dynamics comprehensively evaluates R&D efforts for six high-profile immune/inflammatory disorders: Rheumatoid more…

The mAb Sector Analysis Tool presents the marketed and R&D portfolios, technology focus and product development strategies of over 100 key players in the mAbs market. more…

The monoclonal antibody market is one of the fastest growing and most lucrative sectors of the pharmaceutical industry, with exceptional 48.1% growth between 2003 and 2004. more…

Overview of NHL including epidemiology, etiology, clinical features,staging and prognostic variables more…

This report provides a comprehensive look at the usage patterns for these products, including the sources, formats and unit sizes of antibodies currently purchased as well as more…

Antiviral drugs are the main, if only, method of treatment of major viral disease conditions. more…

Gene therapy has suffered some serious setbacks in the last few years and progress has been considerably slower than many people - particularly investors - had hoped for. more…

This report provides an overview of the gene expression process and how antisense compounds can be used to control gene expression. A summary is provided of the technological more…

This report, based on half a dozen interviews with leading experts in the field, examines business and technological trends fueling the use of monoclonal antibodies in drug more…

This report analyzes and assesses therapeutic and in vivo diagnostic imaging applications of antibodies in human medicine. Included in this report are analyses of monoclonal more…

This Analysis provides evaluation of new compounds in development for asthma and their ability to satisfy the unmet needs of the marke and identification of opportunities for more…

The aim of this report is to provide a range of information, from detailed market analyses through industry trends, to quantify and qualify the emerging market for monoclonal more…